Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)

SERPINA12; OL-64; Visceral Adipose-Specific SERPIN; Serine Proteinase Inhibitor,Clade A Member 12; Visceral adipose-specific serpin

  • Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) Packages (Simulation)
  • Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin) Packages (Simulation)
  • RPA706Mu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)

USAGE of the Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Visceral Adipose Tissue Derived Serine Protease Inhibitor (Vaspin)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GUESTBOOK